Patent details

Basic Information

Publication number:

EP1968594

PCT Application Number:

PCT/US/2006/045776

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP068386358

PCT Publication Number:

WO/2007/064752

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF OCULAR NEOVASCULAR DISORDERS SUCH AS MACULAR DEGENERATION, ANGIOD STREAKS, UVEITIS AND MACULAR EDEMA

French Title of Invention:

TRAITEMENT DE TROUBLES NEOVASCULAIRES OCULAIRES COMME PAR EXAMPLE DÈGÈNERESENCE MACULAIRE, UVEITE ET OEDÈME MACULAIRE

German Title of Invention:

BEHANDLUNG VON NEOVASKULÄREN AUGENERKRANKUNGEN, WIE Z.B. MACULADEGENERATION, ANGIOIDEN STREIFEN, UVEITIS UND MAKULAÖDEMEN

SPC Number:

Dates

Filing date:

29/11/2006

Grant date:

29/09/2010

EP Publication Date:

29/09/2010

PCT Publication Date:

07/06/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/09/2008

EP B1 Publication Date:

29/09/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/11/2014

Expiration date:

29/11/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/11/2006

 

 

Name:

GlaxoSmithKline LLC

Address:

One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102, United States (US)

Agent

Name:

KIRKPATRICK SA / NV

From:

16/12/2010

Address:

AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)

To:

Inventor

1

Name:

MILLER William Henry

Address:

United States (US)

2

Name:

BRIGANDI Richard Anthony

Address:

United States (US)

3

Name:

LEVICK Mark

Address:

United States (US)

Priority

Priority Number:

740478 P

Priority Date:

29/11/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/506;

Filing date	Document type	Number of pages